openPR Logo
Press release

Flu Vaccine Market Size, Share, Growth and Trends, Report 2024-2031

09-11-2024 02:06 PM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Flu Vaccine Market || 2024-2031

Flu Vaccine Market || 2024-2031

The Flu Vaccine Market is expected to grow at a CAGR of 8.8% during the forecast period 2024-2031.

The flu vaccine market refers to the segment of the healthcare industry dedicated to the production, distribution, and administration of vaccines designed to protect against influenza (flu) viruses. These vaccines are developed to prevent influenza, which is a contagious respiratory illness caused by influenza viruses.

Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/flu-vaccine-market

Market Dynamics:

Sustained investments help to scale-up production of tailor-made flu vaccines

The growing demand for universal flu vaccines is driving innovation and investment in science and financing to explore new opportunities. As influenza strains rapidly evolve, existing flu vaccine production technologies are struggling to keep pace, potentially leading to higher costs for flu shots, which poses a concern for individuals. To address this challenge, continuous investment in both technical advancements and financial resources is essential for developing universal flu vaccines. Key players in the flu vaccine market are focusing on enhancing manufacturing processes to produce more customized vaccines. A universal flu vaccine, capable of protecting against all flu strains with a single shot, is an emerging concept that is gaining traction among market players. Additionally, manufacturers are concentrating on mini-HA (Hemagglutinin) antigens, which are components of the flu virus found in various other viruses. Universal flu vaccines could reduce the need for annual updates, thereby lowering costs for researchers and pharmaceutical companies.

Segment Covered in the Flu Vaccine Market:

By Type: Whole virus vaccines, Split virus vaccines, Subunit vaccines, Live attenuated virus vaccines.

By Distribution Channel: Institutional, Hospitals, Community Clinics, Public health agencies, Workplaces, Retails, Retail pharmacy, Mail order pharmacy.

By Application: For Children below 3 years, For Adults and Children over 3 years.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/flu-vaccine-market

Key players involved in Flu Vaccine Market:

• AstraZeneca
• GlaxoSmithKline PLC
• Sanofi
• Abbott Laboratories
• Seqirus
• Mitsubishi Tanabe Pharma
• Serum Institute of India Pvt. Ltd
• Mylan NV
• GDK Biotechnology
• Hualan Biological Engineering Inc.
• Adimmune Corporation
• Sinovac Biotech
• Changchun Institute of Biological Products

*Note:

• Additionally, I wanted to highlight that the full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted.

Regional Analysis:

The Flu Vaccine Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Flu Vaccine Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Related Reports:

Pulmonary Drugs Market: https://www.datamintelligence.com/research-report/pulmonary-drugs-market

Diabetic Foot Ulcers Market: https://www.datamintelligence.com/research-report/diabetic-foot-ulcers-market

Diabetic Retinopathy Market: https://www.datamintelligence.com/research-report/diabetic-retinopathy-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Flu Vaccine Market Size, Share, Growth and Trends, Report 2024-2031 here

News-ID: 3652385 • Views:

More Releases from DataM Intelligence 4Market Research

United States Peripheral Neuropathy Market Set for Transformative Growth with Rising Treatment Innovations 2025 | Top key players - GlaxoSmithKline, Abbott Laboratories, Cipla Laboratories.
United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth: The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031). The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancements in Treatment & Rising Cardiovascular Cases 2025 | Top key players - Merck, Novartis, Amgen Inc.
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth: The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031. The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and Rising Patient Demand 2025 | Top key players - AdvaCare Pharma, Sanofi, Pfizer Inc.
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth: The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033. The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth with Innovative Therapies Revolutionizing Oncology Care 2025 | Major key players - BioNTech SE, Merck & Co., Inc., Moderna, Inc.
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth: The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033. The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in

All 5 Releases


More Releases for Flu

Bird Flu Market Safeguarding Flocks, Securing Health: The Bird Flu Challenge in …
Bird Flu Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bird Flu Market - (By Virus Type (H5N1, H7N9, H5N6, H5N8, H10N8, H9N2, Others), By Test Type (PCR Tests, ELISA Tests, Hemagglutination Assays, Virus Isolation Tests, Next Generation Sequencing, Others), By Treatment Type (Vaccines, Antiviral Medication, Immunomodulators, Others),
Microneedle Flu Vaccine Market New develop microneedle patch for flu vaccination
Drug delivery through the skin by transdermal patches has always been effective against viral infection and flu. Drug delivery through transdermal route is mainly effective due to passive diffusion of the drug and followed by drug development in transdermal delivery systems through different mechanism of action such as iontophorresis and sonophoresis. Moreover, pharmaceutical companies are focusing on development of micro-needle vaccines due to its immense utility in transdermal delivery of
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Researchers Develop Microneedle Flu Vaccine for flu vaccination
New research funding to develop commercially available micro needle flu vaccine, which would pace up the launch of these products. In 2015, the Georgia Institute of Technology and Micron Biomedical were awarded US$ 2.5 million in grants from the Bill & Melinda Gates Foundation to advance the development of dissolvable microneedle patches for polio immunization. This would also widen up the disease profile for which microneedle vaccine could be developed. Growing
Canine Flu Therapeutics Market 2019| To Develop Therapeutics For The Flu To Cont …
"Canine Flu Therapeutics Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028" is the latest addition to MarketResearchReports.Biz industry research reports collection. Canine flu (also known as dog flu) is a contagious respiratory disease in dogs mainly caused by Type A influenza/canine influenza virus. They are two various kinds of influenza viruses namely H3N8 virus and H3N2. Canine flu originated in horses, spread to dogs, and now spreads in between dogs
Sunshine vitamin prevents flu
The vitamin D supply is one of the key factors for the outbreak and the course of influenza epidemics. Norwegian scientists have drawn this conclusion from a study on influenza epidemics, which has now been published in the specialist journal “International Journal of Infectious Diseases”. According to this study, with these influenza epidemics the infection and mortality rates increase with decreasing exposure to sunlight and thus, with decreasing vitamin D